Phase I, first-in-human study of XTR004, a novel 18F-labeled tracer for myocardial perfusion PET: Biodistribution, radiation dosimetry, pharmacokinetics, and safety after a single injection at rest

Ren, Chao; Pan, Qingqing; Fu, Chao; Wang, Peipei; Zheng, Zhiquan; Hsu, Bailing; Huo, Li

Phase I, first-in-human study of XTR004, a novel 18F-labeled tracer for myocardial perfusion PET: Biodistribution, radiation dosimetry, pharmacokinetics, and safety after a single injection at rest

journal contribution

posted on 2024-10-10, 04:35 authored by Chao Ren, Qingqing Pan, Chao Fu, Peipei WangPeipei Wang, Zhiquan Zheng, Bailing Hsu, Li Huo

Phase I, first-in-human study of XTR004, a novel 18F-labeled tracer for myocardial perfusion PET: Biodistribution, radiation dosimetry, pharmacokinetics, and safety after a single injection at rest

History

Journal

Journal of Nuclear Cardiology

Volume

34

Article number

101823

Pagination

1-13

Location

Amsterdam, The Netherlands

Publisher DOI

https://doi.org/10.1016/j.nuclcard.2024.101823

Open access

No

ISSN

1071-3581

eISSN

1532-6551

Language

eng

Publication classification

C1.1 Refereed article in a scholarly journal

Publisher

Elsevier

Publication URL

http://dx.doi.org/10.1016/j.nuclcard.2024.101823

Phase I, first-in-human study of XTR004, a novel 18F-labeled tracer for myocardial perfusion PET: Biodistribution, radiation dosimetry, pharmacokinetics, and safety after a single injection at rest

History

Journal

Volume

Article number

Pagination

Location

Publisher DOI

Open access

ISSN

eISSN

Language

Publication classification

Publisher

Publication URL

Usage metrics

Categories

Keywords

Licence

Exports